An Alternative Terminal Step of the General Secretory Pathway in Staphylococcus aureus.
Type I signal peptidase (SPase) is essential for viability in wild-type bacteria because the terminal step of the bacterial general secretory pathway requires its proteolytic activity to release proteins from their membrane-bound N-terminal leader sequences after translocation across the cytoplasmic membrane. Here, we identify the Staphylococcus aureus operon ayrRABC (SA0337 to SA0340) and show that once released from repression by AyrR, the protein products AyrABC together confer resistance to the SPase inhibitor arylomycin M131 by providing an alternate and novel method of releasing translocated proteins. Thus, the derepression of ayrRABC allows cells to bypass the essentiality of SPase. We demonstrate that AyrABC functionally complements SPase by mediating the processing of the normally secreted proteins, albeit in some cases with reduced efficiency and either without cleavage or via cleavage at a site N-terminal to the canonical SPase cleavage site. Thus, ayrRABC encodes a secretion stress-inducible alternate terminal step of the general secretory pathway. IMPORTANCE : Addressing proteins for proper localization within or outside a cell in both eukaryotes and prokaryotes is often accomplished with intrinsic signals which mediate membrane translocation and which ultimately must be removed. The canonical enzyme responsible for the removal of translocation signals is bacterial type I signal peptidase (SPase), which functions at the terminal step of the general secretory pathway and is thus essential in wild-type bacteria. Here, we identify a four-gene operon in S. aureus that encodes an alternate terminal step of the general secretory pathway and thus makes SPase nonessential. The results have important implications for protein secretion in bacteria and potentially for protein trafficking in prokaryotes and eukaryotes in general.
Department of Chemistry, The Scripps Research Institute, La Jolla, California, USA.
Arryn
A
Craney
The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, La Jolla, California, USA.
Melissa M
MM
Dix
Department of Chemistry, The Scripps Research Institute, La Jolla, California, USA.
Ramkrishna
R
Adhikary
The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, La Jolla, California, USA.
Benjamin F
BF
Cravatt
Department of Chemistry, The Scripps Research Institute, La Jolla, California, USA floyd@scripps.edu.
Floyd E
FE
Romesberg
D001426:Bacterial Proteins / Q000235:genetics* / Q000378:metabolism; D010450:Endopeptidases / Q000172:deficiency / Q000235:genetics; D008565:Membrane Proteins / Q000378:metabolism; D008958:Models, Molecular; D009876:Operon; D011487:Protein Conformation; D021382:Protein Sorting Signals; D021381:Protein Transport / Q000235:genetics; D020543:Proteome; D055571:Secretory Pathway / Q000235:genetics* / Q000502:physiology; D012697:Serine Endopeptidases / Q000378:metabolism; D013211:Staphylococcus aureus / Q000235:genetics* / Q000378:metabolism*
D001426:Bacterial Proteins; D008565:Membrane Proteins; D021382:Protein Sorting Signals; D020543:Proteome; D010450:Endopeptidases; D012697:Serine Endopeptidases; C026515:type I signal peptidase; C075054:glutamic acid-specific endopeptidase, Staphylococcus aureus